Tina N. Davis

发表

Direct inhibition of the NOTCH transcription factor complex

Raymond E. Moellering, Melanie Cornejo, Tina N. Davis, 2010, Nature.

A stapled p53 helix overcomes HDMX-mediated suppression of p53.

Tina N. Davis, Andrew L Kung, G. Wahl, 2010, Cancer cell.

Direct inhibition of the NOTCH transcription factor complex

Raymond E. Moellering, Melanie Cornejo, Tina N. Davis, 2009, Nature.

HOXA9 is required for survival in human MLL-rearranged acute leukemias.

Tina N. Davis, Andrew L Kung, Scott A Armstrong, 2009, Blood.

Selective Inhibition of HDAC 1 and HDAC 2 as a Potential Therapeutic Option for BALL Short title : BALLs are sensitive to an HDAC 1 / HDAC 2 inhibitor

Tina N. Davis, S. Armstrong, J. Qi, 2015 .

Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL

Tina N. Davis, S. Armstrong, J. Qi, 2015, Clinical Cancer Research.

Proteomic and genetic approaches identify Syk as an AML target.

Tina N. Davis, Steven A Carr, William C Hahn, 2009, Cancer cell.

In Vivo Pharmacodynamic Imaging of Proteasome Inhibition

Tina N. Davis, J. Bradner, A. Kung, 2009, Molecular imaging.

Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.

Tina N. Davis, R. D'Amato, C. Becker, 2011, Fertility and sterility.

Correction: Preservation of myocardial contractility during acute hypoxia with OMX-CV, a novel oxygen delivery biotherapeutic

Tina N. Davis, V. Ivaturi, J. Gobburu, 2019, PLoS biology.

Selective Inhibition of HDAC1 and HDAC2 Is a Potential Therapeutic Option for B-All

Tina N. Davis, S. Armstrong, J. Qi, 2010 .

leukemias -rearranged acute MLL HOXA9 is required for survival in human

Tina N. Davis, S. Armstrong, C. Zwaan, 2009 .

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Preservation of myocardial contractility during acute hypoxia with OMX-CV, a novel oxygen delivery biotherapeutic

Tina N. Davis, V. Ivaturi, J. Gobburu, 2018, PLoS biology.

Systematic in vivo structure-function analysis of p300 in hematopoiesis.

Tina N. Davis, A. Kung, M. Lemieux, 2009, Blood.

A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo.

Tina N. Davis, David R. Liu, Jen-Chieh Tseng, 2011, Chemistry & biology.

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis

Tina N. Davis, R. D'Amato, C. Becker, 2013, Angiogenesis.

DOT1L and Histone H3 Lysine79 Methylation as a Therapeutic Target in Mixed Lineage Leukemia.

Tina N. Davis, S. Armstrong, A. Kung, 2009 .

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis

Tina N. Davis, R. D'Amato, C. Becker, 2013, Angiogenesis.

Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL

Tina N. Davis, S. Armstrong, J. Qi, 2015, Clinical Cancer Research.

A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo.

Tina N. Davis, David R. Liu, Kevin T. Beier, 2011, Chemistry & biology.